ENZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ENZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Enzo Biochem's EBITDA per Share for the three months ended in Jan. 2024 was $-0.02.
During the past 3 years, the average EBITDA Per Share Growth Rate was 16.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Enzo Biochem was 206.10% per year. The lowest was -381.30% per year. And the median was 17.40% per year.
For the Diagnostics & Research subindustry, Enzo Biochem's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Enzo Biochem (NYSE:ENZ) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Thank you for viewing the detailed overview of Enzo Biochem's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Steven J Pully | director | 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042 |
James G. Wolf | 10 percent owner | 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455 |
Hamid Erfanian | officer: Chief Executive Officer | 527 MADISON AVENUE, NEW YORK NY 10022 |
Patricia Eckert | officer: Interim CFO | C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735 |
Kara Cannon | officer: Chief Operating Officer | 527 MADISON AVE, NEW YORK NY 10022 |
Bradley Louis Radoff | director | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
David Bench | officer: CHIEF FINANCIAL OFFICER | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Harbert Discovery Fund, Lp | 10 percent owner | HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Ian B. Walters | director | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Mary Tagliaferri | director | 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Clemens Peter J Iv | 10 percent owner | 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069 |
Rebecca J. Fischer | director | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Fabian Blank | 10 percent owner, other: See Remarks | ROEMERSTRASSE 6, BAD BERTRICH 2M 56864 |
Harbert Management Corp | 10 percent owner | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Harbert Discovery Co-investment Fund I Gp, Llc | 10 percent owner | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 04-06-2022
By Marketwired • 09-06-2023
By GuruFocusNews GuruFocusNews • 07-02-2022
By GlobeNewswire GlobeNewswire • 06-02-2022
By Value_Insider Value_Insider • 10-20-2022
By GuruFocusNews GuruFocusNews • 06-16-2022
By GuruFocusNews GuruFocusNews • 06-12-2022
By GuruFocusNews GuruFocusNews • 06-26-2022
By PurpleRose PurpleRose • 08-03-2022
By GuruFocusNews GuruFocusNews • 06-06-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.